Top Story

BLOG: Why retina specialists should participate in clinical trials

March 28, 2015

For retina specialists, participating in clinical trials can be a rewarding opportunity for professional growth. And while the decision to include clinical trials at a retina practice is one that should be made after careful consideration and planning, there are several benefits to consider.

First, clinical trials expose retina specialists to groundbreaking innovations in therapy, including cutting-edge devices and novel mechanisms of action. Clinicians and their staff are fortunate to learn about new therapies before they are available on the market, placing them a step ahead of their peers.

Business News

pSivida completes enrollment for phase 3 trial of Medidur for posterior uveitis

March 27, 2015
pSivida completed the target enrollment of 120 patients in a phase 3 clinical trial of Medidur to treat posterior uveitis, according to a press release.The double-masked…
Business News

Enhanced BLIS injector system available from Bausch + Lomb

March 27, 2015
An enhanced BLIS injector system is now available, Bausch + Lomb announced in a press release.BLIS was designed exclusively for use with the enVista hydrophobic acrylic…
In the Journals

Spectral-domain OCT may reliably measure stromal bed thickness during LASIK

March 27, 2015
Intraoperative spectral-domain OCT may be a reliable alternative to measure stromal bed thickness before lifting the flap during LASIK surgery, according to a…
Breaking News

Senate adjourns without voting on bill to repeal sustainable growth rate

March 27, 2015
The U.S. Senate left for its 2-week spring break without voting on a bill that repeals the sustainable growth rate, leaving physicians to face a 21% payment cut if…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina
Online Advanced Release, March 5, 2015
More »
CME
Challenges and Solutions in Retinal Vascular Disease: Pigment Epithelial Detachment and Refractory Diabetic Macular Edema

Challenges and Solutions in Retinal Vascular Disease: Pigment Epithelial Detachment and Refractory Diabetic Macular Edema

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

With anti-VEGF therapy well-established as front-line therapy in the management of age-related macular degeneration and…
More »
Meeting News Coverage Video
thumbnail for video 4131356728001

VIDEO: Speaker discusses the advantages of swept source OCT

March 24, 2015
At Retina 2015, SriniVas Sadda, MD, discusses the advantages of swept source OCT over existing commercial SD-OCT…
More »
morganatic-roan